Stock 603077 SICHUAN HEBANG BIOTECHNOLOGY CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Sichuan Hebang Biotechnology Corporation Limited

Equities

603077

CNE100001JM9

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-05 EDT 		5-day change 1st Jan Change
2.16 CNY +2.86% Intraday chart for Sichuan Hebang Biotechnology Corporation Limited +5.37% -8.47%
04-19 Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-02 Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on January 25, 2024. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on January 25, 2024.
CI
Yapp Automotive Parts Vice Chairman Resigns
MT
Chinese provinces target modest 2024 growth after missing previous goals
RE
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.
CI
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.
CI
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on December 15, 2023, has closed with 168,811,563 shares, representing 1.93% for CNY 389.79 million.
CI
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.
CI
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.
CI
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.
CI
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on October 19, 2023.
CI
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.
CI
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on October 19, 2023, has closed with 170,337,200 shares, representing 1.95% for CNY 399.89 million.
CI
Avenira Limited announced that it has received AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited
CI
Sichuan Hebang Biotechnology Corporation Limited(SHSE:603077) dropped from Shanghai Stock Exchange 180 Value Index
CI
Sichuan Hebang Biotechnology Corporation Limited(SHSE:603077) dropped from SSE 180 Index
CI
Hebang Biotechnology to Buy 10.5% Stake in Australia-Listed Avenira For AU$2 Million
MT
Avenira Limited announced that it expects to receive AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited
CI
Sichuan Salt Industry Corporation and Sichuan Salt Industry Group West Sichuan Co., Ltd. agreed to acquire 49% stake in Sichuan Shuncheng Salt Products Co., Ltd from Sichuan Hebang Biotechnology Corporation Limited for approximately CNY 150 million.
CI
Chinese graduates hold off career dreams, take temporary government jobs
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603077 Stock
  4. News Sichuan Hebang Biotechnology Corporation Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW